Transient Receptor Potential Vanilloid 4-Dependent Microglial Function in Myelin Injury and Repair

Jameson P Holloman1, Sophia H Dimas2, Angela S Archambault1

  • 1Department of Neurology, Washington University School of Medicine, Saint Louis, MO 63110, USA.

Summary

Transient receptor potential vanilloid 4 (TRPV4) deletion enhances microglial phagocytosis but does not affect multiple sclerosis (MS) disease severity or demyelination in mouse models. TRPV4 appears to have a limited role in MS pathogenesis.

Related Concept Videos